122 related articles for article (PubMed ID: 15073260)
1. Proposed addendum to previously published fetal dose estimate tables for 18F-FDG.
Stabin MG
J Nucl Med; 2004 Apr; 45(4):634-5. PubMed ID: 15073260
[TBL] [Abstract][Full Text] [Related]
2. Absorbed 18F-FDG dose to the fetus during early pregnancy.
Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
[TBL] [Abstract][Full Text] [Related]
3. In vivo quantification of 18f-fdg uptake in human placenta during early pregnancy.
Zanotti-Fregonara P; Jan S; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
Health Phys; 2009 Jul; 97(1):82-5. PubMed ID: 19509511
[TBL] [Abstract][Full Text] [Related]
4. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
5. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
Zanotti-Fregonara P; Laforest R; Wallis JW
J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.
Zanotti-Fregonara P; Koroscil TM; Mantil J; Satter M
Health Phys; 2012 Feb; 102(2):217-9. PubMed ID: 22217594
[TBL] [Abstract][Full Text] [Related]
7. Doses to fetal and maternal organs from intravenous 59FeCl3 or 57CoCl2.
Saunders M; Palmer AM; Millard RK; Preece AW
Radiat Prot Dosimetry; 2003; 106(1):63-9. PubMed ID: 14653327
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
Pencharz D; McMeekin H; Wagner T; Wickham F
Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065
[TBL] [Abstract][Full Text] [Related]
9. Maternal-fetal in vivo imaging: a combined PET and MRI study.
Benveniste H; Fowler JS; Rooney WD; Moller DH; Backus WW; Warner DA; Carter P; King P; Scharf B; Alexoff DA; Ma Y; Vaska P; Schlyer D; Volkow ND; ;
J Nucl Med; 2003 Sep; 44(9):1522-30. PubMed ID: 12960202
[TBL] [Abstract][Full Text] [Related]
10.
Zanotti-Fregonara P; Ishiguro T; Yoshihara K; Ishii S; Enomoto T
J Nucl Med; 2022 Oct; 63(10):1592-1597. PubMed ID: 35115366
[TBL] [Abstract][Full Text] [Related]
11. Radiation-absorbed dose from 201Tl-thallous chloride.
Thomas SR; Stabin MG; Castronovo FP
J Nucl Med; 2005 Mar; 46(3):502-8. PubMed ID: 15750165
[TBL] [Abstract][Full Text] [Related]
12. Model-based comparison of maternal and foetal organ doses from (99m)Tc pertechnetate, DMSA, DTPA, HDP, MAA and MAG(3) diagnostic intakes during pregnancy.
Saunders M; Palmer M; Preece A; Millard R
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1365-73. PubMed ID: 12271420
[TBL] [Abstract][Full Text] [Related]
13. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Xie T; Zaidi H
J Nucl Med; 2014 Sep; 55(9):1459-66. PubMed ID: 25024424
[TBL] [Abstract][Full Text] [Related]
14. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
Keleher A; Wendt R; Delpassand E; Stachowiak AM; Kuerer HM
Breast J; 2004; 10(6):492-5. PubMed ID: 15569204
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
17. Estimated Fetal Radiation Dose From 18 F-FDG PET/CT During the Second and Third Trimesters of Pregnancy.
Al Mansour L; Tylski P; Chene G; Plaisant F; Janier M; Bolze PA; You B; Defez D; Tordo J; Flaus A
Clin Nucl Med; 2024 Jul; 49(7):605-609. PubMed ID: 38778468
[TBL] [Abstract][Full Text] [Related]
18. Placental binding and transfer of radiopharmaceuticals: technetium-99m d, 1-HMPAO.
Owunwanne A; Omu A; Patel M; Mathew M; Ayesha A; Gopinath S
J Nucl Med; 1998 Oct; 39(10):1810-3. PubMed ID: 9776293
[TBL] [Abstract][Full Text] [Related]
19. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
20. Transfer of 14C to prenatal and neonatal rats from their mothers exposed to 14C compounds by ingestion.
Takeda H; Fuma S; Miyamoto K; Kuroda N; Inaba J
Radiat Prot Dosimetry; 2003; 105(1-4):291-6. PubMed ID: 14526973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
